Cite
HARVARD Citation
Morabito, F. et al. (2022). Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients. European journal of haematology. pp. 178-189. [Online].